I see that CSL has announced that sales of its HPV vaccine will come in US$500m below its previous guidance...implications for the HPV testing market?
no near term impact i wouldn't have thought, but any counter views?
also heard on Nova 96.9 news this morning that gardisal effectiveness was expected to result in a 97% decrease in cervical cancer levels in the longer term.
sounded like garbage to me. i thought that the 2 high-risk types that gardisal provides protection against only account for 70% of all cervical cancer??
- Forums
- ASX - By Stock
- GBI
- gardisal sales disappoint
gardisal sales disappoint
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GBI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online